CAPTRUST Financial Advisors
VCNX

CAPTRUST Financial Advisors’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24
Closed -$5K – 4229
2022
Q2 		$5K Buy
+24
New +$6.13K ﹤0.01% 4133

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

CAPTRUST Financial Advisors's VCNX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2022, closing a stake of 24 shares — an estimated $5K sold.

CAPTRUST Financial Advisors first reported a position in VCNX in Q2 2022 and held it in 1 quarter. The position peaked at $5K in Q2 2022. 22 funds tracked by Wall St. Rank hold VCNX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 24 Vaccinex, Inc. Common Stock shares in Q3 2022, an estimated $5K.
  • CAPTRUST Financial Advisors first reported a position in Vaccinex, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Vaccinex, Inc. Common Stock position peaked at $5K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.